Loading…

Smiths Medical partnered with BARDA and the Department of Defense to expand capacity at its Keene, New Hampshire facility for production of hypodermic needle and syringe products. BARDA will invest $20 million into a $38 million capital expansion project, increasing needle production capacity by 125 million units per year.
“BARDA, in collaboration with JPEO-CBRND, will invest $20 million into a $38 million capital expansion project to further expand Smiths Medical's production operations in Keene, New Hampshire.”biospace.com
Summarized from public sources; check the original articles before acting on it.